Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects
Acta Pharmaceutica Sinica B · 2023-05 · 13 (5) · 2138-2151
DOI: 10.1016/j.apsb.2022.12.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-05. Verfasst von Wei Wei und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Wei, W., Zeng, Q., Wang, Y., Guo, X., Fan, T., Li, Y., Deng, H., Zhao, L., Zhang, X., Liu, Y., Shi, Y., Zhu, J., Ma, X., Wang, Y., Jiang, J., & Song, D. (2023). Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharmaceutica Sinica B, 13(5), 2138-2151. https://doi.org/10.1016/j.apsb.2022.12.009
Vancouver
Wei W, Zeng Q, Wang Y, Guo X, Fan T, Li Y, et al. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharmaceutica Sinica B. 2023;13(5):2138-2151. doi:10.1016/j.apsb.2022.12.009
BibTeX
@article{Wei2023,
author = {Wei, Wei and Zeng, Qingxuan and Wang, Yan and Guo, Xixi and Fan, Tianyun and Li, Yinghong and Deng, Hongbin and Zhao, Liping and Zhang, Xintong and Liu, Yonghua and Shi, Yulong and Zhu, Jingyang and Ma, Xican and Wang, Yanxiang and Jiang, Jiandong and Song, Danqing},
title = {Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {5},
pages = {2138--2151},
doi = {10.1016/j.apsb.2022.12.009}
}
EUVIMED